Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study
Gespeichert in:
Verfasser / Beitragende:
[T. André, A. de Gramont, D. Vernerey, B. Chibaudel, F. Bonnetain, A. Tijeras-Raballand, A. Scriva, T. Hickish, J. Tabernero, J.L. Van Laethem, M. Banzi, E. Maartense, E. Shmueli, G.U. Carlsson, W. Scheithauer, D. Papamichael, M. Möehler, S. Landolfi, P. Demetter, S. Colote, C. Tournigand, C. Louvet, A. Duval, J.F. Fléjou, A. de Gramont]
Ort, Verlag, Jahr:
2015
Enthalten in:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 33/35(2015), 4176-4187
Format:
Artikel (online)
Verfasser / Beitragende
- André, T.
- de Gramont, A.
- Vernerey, D.
- Chibaudel, B.
- Bonnetain, F.
- Tijeras-Raballand, A.
- Scriva, A.
- Hickish, T.
- Tabernero, J.
- Van Laethem, J.L.
- Banzi, M.
- Maartense, E.
- Shmueli, E.
- Carlsson, G.U.
- Scheithauer, W.
- Papamichael, D.
- Möehler, M.
- Landolfi, S.
- Demetter, P.
- Colote, S.
- Tournigand, C.
- Louvet, C.
- Duval, A.
- Fléjou, J.F.